RAPT Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAPT and other ETFs, options, and stocks.About RAPT
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
RAPT Key Statistics
Stock Snapshot
As of today, RAPT Therapeutics(RAPT) shares are valued at $57.58. The company's market cap stands at 1.6B, with a P/E ratio of -3.17.
During the trading session on 2026-01-20, RAPT Therapeutics(RAPT) shares reached a daily high of $57.61 and a low of $57.41. At a current price of $57.58, the stock is +0.3% higher than the low and still -0.1% under the high.
Trading activity shows a volume of 31.93M, compared to an average daily volume of 300.53K.
The stock's 52-week range extends from a low of $5.67 to a high of $57.61.
The stock's 52-week range extends from a low of $5.67 to a high of $57.61.
RAPT News
Claim 70% Off TipRanks Premium RAPT Therapeutics ( (RAPT) ) has provided an announcement. On January 14, 2026, RAPT Therapeutics presented at the 44th Annual...